InMed Pharmaceuticals Inc. (IN.TO) (TSE:IN) Shares Gap Up to $5.58


Share on StockTwits

InMed Pharmaceuticals Inc. (IN.TO) (TSE:IN)’s share price gapped up before the market opened on Tuesday . The stock had previously closed at C$5.58, but opened at C$6.27. InMed Pharmaceuticals Inc. (IN.TO) shares last traded at C$5.75, with a volume of 2,892 shares.

The firm has a market capitalization of C$46.45 million and a price-to-earnings ratio of -4.14. The company has a fifty day moving average price of C$5.60 and a two-hundred day moving average price of C$4.07. The company has a current ratio of 4.76, a quick ratio of 4.73 and a debt-to-equity ratio of 4.15.

InMed Pharmaceuticals Inc. (IN.TO) (TSE:IN) last released its quarterly earnings data on Thursday, February 11th. The company reported C($0.48) EPS for the quarter, missing analysts’ consensus estimates of C($0.30) by C($0.18). As a group, equities research analysts expect that InMed Pharmaceuticals Inc. will post -1.47 earnings per share for the current year.

About InMed Pharmaceuticals Inc. (IN.TO) (TSE:IN)

InMed Pharmaceuticals Inc, a clinical stage pharmaceutical company, researches and develops cannabinoid-based therapies. The company's lead product is INM-755, a cannabinol topical cream, which is in a second Phase I clinical trials for the treatment of epidermolysis bullosa. The company is also involved in developing INM-088, which is in preclinical studies for the treatment of glaucoma; and INM-405 for the treatment of orofacial pain.

See Also: Holder of Record

Receive News & Ratings for InMed Pharmaceuticals Inc. (IN.TO) Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for InMed Pharmaceuticals Inc. (IN.TO) and related companies with MarketBeat.com's FREE daily email newsletter.